Discover 568 paid clinical trials in Norman, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 568
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Bartlesville OK, Plano TX, Dallas TX, Amarillo TX,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase3, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
for
Acne
Location: Oklahoma City OK, Prosper TX, Carrollton TX, Katy TX,
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All
Age: 18 - 45
Code: NCT06316297
Phase1, Phase2, Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
for
Moderate-to-Severe Atopic Dermatitis
Location: Oklahoma City OK, North Little Rock AR, Omaha NE,
Sponsor: Nektar Therapeutics
Sex: All
Age: 12+
Code: NCT07690371
Phase3, Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
for
Aortic Stenosis
Location: Oklahoma City OK, Wichita KS, Kansas City KS,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 18 - 70+
Code: NCT06777368
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
for
Osteoarthritis Knee Pain
Location: Edmond OK, Tyler TX, Bellaire TX, Greenwood Village CO,
Sponsor: Saol Therapeutics Inc
Sex: All
Age: 40+
Code: NCT07226258
Phase3, Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
for
Degenerative Disc Disease (DDD)
Location: Edmond OK, Tyler TX, Shreveport LA, Overland Park KS,
Sponsor: ReGelTec, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06011551
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype